protocol-design-995x60.png protocol-design-995x60.png

FEATURED ARTICLES

  • Lilly Makes It Easier For Physicians To Become Investigators
    Lilly Makes It Easier For Physicians To Become Investigators

    As the global head of clinical innovation for Eli Lilly and Company, Katherine Vandebelt knows there are many things pharma needs to do better. No drug can make it to market without first navigating the clinical trials process, which creates a burden on the physicians involved. Therefore, it should come as no surprise to anyone involved in the process that many physicians will oversee one trial and then opt to no longer take part in them.

  • Are Outdated Pricing Models Hurting Clinical Research?
    Are Outdated Pricing Models Hurting Clinical Research?

    Two issues that always seem to throw a wrench into sponsor/CROs relationships are changes to staffing and pricing. Protocol changes can disrupt trials for CROs and cause price increases for sponsors. Staffing changes can create new learning curves, delay trials, and cause sponsors to feel they were misled. Are penalties an easy way to fix both?

  • PatientsLikeMe And Duke Bring Novel Approach To ALS Trial
    PatientsLikeMe And Duke Bring Novel Approach To ALS Trial

    Can the peptide Lunasin help to reverse the debilitating effects of ALS? After one patient (and three experts) noted it could, PatientsLikeMe and the Duke ALS Clinic decided to get involved. Their novel trial will feature an unlimited number of patients, sharing of all patient data, and electronic patient reported outcomes. It also eliminated the use of a placebo.

More Featured Articles

WHITE PAPERS AND CASE STUDIES

  • What The Fitbit Is Helping Pharma Learn About Patients
    What The Fitbit Is Helping Pharma Learn About Patients

    Fitness trackers were popular holiday gifts this year and sales are on the rise. While counting steps and getting fit may be the primary reason consumers are purchasing Fitbits and other wearables, other sensors these devices include, such as heart rate and sleep monitors, could actually help big pharma collect a wealth of valuable data to revolutionize personalized medicine.

  • End-To-End Management Of Clinical Trials Data
    End-To-End Management Of Clinical Trials Data

    The introduction of electronic data capture (EDC) systems in clinical trial data management and analysis triggered the promise of better-managed clinical trials – with greater efficiency, faster access to higher-quality clinical data and better mapping of data flows to business processes.

  • Moving Towards An Electronic Environment In Clinical Trials

    With each passing year, clinical trials are becoming increasingly global. The business of product development is moving away from the traditional model in which studies are conducted primarily in the US – in fact, recent estimates indicate that within the next three years, up to 65 per cent of studies under FDA regulation will be conducted outside the US. A review of a US government clinical trials registry and of 300 published reports in major medical journals revealed that one third (157 of 509) of Phase III trials were being conducted entirely outside the US, with over half the study sites (13,521 of 24,206) used in these trials located overseas, many in eastern Europe and Asia.

More White Papers & Case Studies

SERVICES AND PRODUCTS

Optimizer: Clinical Supply Chain Planning Technology Optimizer: Clinical Supply Chain Planning Technology

Optimizer is BioClinica's powerful forecasting and demand planning technology used by the world's largest pharmaceutical companies to manage global logistics of the clinical supply chain. Managing supplies based on demand creates opportunities for savings and efficiencies in numerous areas, eliminating the high cost of waste as well as shortages that threaten timelines, budgets and even study integrity.

UX Trial Design™ - Unified Design Tool UX Trial Design™ - Unified Design Tool

DATATRAK ONE® UX Trial Design™ product streamlines the entire design-to-deployment process using a single tool. Trial Designers are able to configure their studies, immediately view their changes in the Design environment and commit the files into the versioning repository.

DATATRAK Clinical and Consulting Services (DCCS) DATATRAK Clinical and Consulting Services (DCCS)

We deliver superior service through our DATATRAK ONE® program by aligning our service delivery processes and our integrated technology.

Imaging Core Lab Services Imaging Core Lab Services

ICON Medical Imaging’s use of superior technology, advanced science and experienced people lead to the ultimate goal: results.

Outcomes Research Outcomes Research

ICON Late Phase and Outcomes Research deliver strategic expertise, high-impact evidence that explores and demonstrates value of healthcare products and meets the demands of the global and national markets for patient reported outcome services.

More Services & Products